New & Updated
Here is a list of recently added titles to Bookshelf and updated books and releases
Recent Releases
Vertical integration of general practices with acute hospitals in England: rapid impact evaluation.
Sidhu M, Saunders CL, Davies C, et al.
Southampton (UK): National Institute for Health and Care Research; 2023 Oct. (Health and Social Care Delivery Research, No. 11.17.)
Forum on Drug Discovery, Development, and Translation; Roundtable on Black Men and Black Women in Science, Engineering, and Medicine; Board on Health Sciences Policy; Board on Population Health and Public Health Practice; U.S. Science and Innovation Policy; Health and Medicine Division; Policy and Global Affairs; National Academies of Sciences, Engineering, and Medicine.
Washington (DC): National Academies Press (US); 2024 May 16.
Prevention and Treatment of Mpox [Internet].
McLean JR, Zucker JE, Vail RM, et al.
Baltimore (MD): Johns Hopkins University; 2024 May.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Chang A, Vannabouathong C, Perras C; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Melatonin for the Treatment of Insomnia in Children and Adolescents: Rapid Review [Internet].
Tran K, Mahood Q; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Lachance CC, Mierzwinski-Urban M; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Pemigatinib (Pemazyre): CADTH Reimbursement Review: Therapeutic area: Cholangiocarcinoma [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
View More Recent Releases
Dyrda P, Vannabouathong C, Peter K, et al.; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Vu T, Butcher R; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Clark M, Li Y, Mahood Q, et al.; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Syphilis Screening for Adolescents and Adults: Rapid Review [Internet].
Barbara AM, Horton J; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Darvesh N, Butcher R; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Toxicological Profile for Hexachlorocyclohexane (HCH).
Atlanta (GA): Agency for Toxic Substances and Disease Registry (US); 2024 Mar.
Tralokinumab (Adtralza): CADTH Reimbursement Review: Therapeutic area: Atopic dermatitis [Internet].
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Intranasal Glucagon for the Treatment of Hypoglycemia: Rapid Review [Internet].
Tran K, MacDougall D; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
eConsult for Provider-to-Provider Consultation: Technology Review [Internet].
Peprah K, Walter M; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Guidelines for Pediatric Immune Thrombocytopenia: Rapid Review [Internet].
Hui D, Barbara A, McGill SC; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Ibrutinib for Chronic Graft-Versus-Host Disease: Rapid Review [Internet].
Khangura SD, Grobelna A; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
Dapagliflozin for Chronic Kidney Disease: Rapid Review with Expert Input [Internet].
Khangura SD, Severn M; Authors.
Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2022 Jun.
